BRCA: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 11: Line 11:


== Structural highlights ==
== Structural highlights ==
The <scene name='75/750267/Cv/1'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>.  These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/2'>Phosphoserine binding</scene>.  
The <scene name='75/750267/Cv/5'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>.  These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/6'>Phosphoserine binding</scene>.  


</StructureSection>
</StructureSection>

Revision as of 11:31, 27 May 2018

Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code 3coj)

Drag the structure with the mouse to rotate

3D structures of BRCA

Updated on 27-May-2018

References

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Jaime Prilusky, Joel L. Sussman